MSD Partners’s Humana HUM Stock Holding History

MSD Partners’s Portfolio HUM Stock Details HUM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-114,957	Closed	-$53.3M	–	104
2021 Q4	$53.3M	Sell	114,957 -68,804	-37%	-$30.4M	0.59%	18
2021 Q3	$71.5M	Buy	183,761 +41,300	+29%	+$17.5M	2.17%	5
2021 Q2	$63.1M	Buy	142,461 +22,895	+19%	+$10M	1.65%	5
2021 Q1	$50.1M	Buy	+119,566	New	+$47.7M	1.9%	9

Other funds holding HUM

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

MSD Partners's HUM Position: Q1 2022 in Review

MSD Partners sold out of Humana (HUM) in Q1 2022, closing a stake of 114,957 shares — an estimated $53.3M sold.

MSD Partners first reported a position in HUM in Q1 2021 and held it in 4 quarters. The position peaked at $71.5M in Q3 2021. 915 funds tracked by Wall St. Rank hold HUM as of Q1 2022.

MSD Partners reported no remaining Humana position as of Q1 2022 after selling out during the quarter.
MSD Partners sold 114,957 Humana shares in Q1 2022, an estimated $53.3M.
MSD Partners first reported a position in Humana in Q1 2021 and held it in 4 quarters.
MSD Partners's Humana position peaked at $71.5M in Q3 2021.
915 funds tracked by Wall St. Rank held Humana as of Q1 2022.

Based on MSD Partners's 13F filing for Q1 2022, filed 16 May 2022.